1. Home
  2. Labeler Index
  3. Glaxosmithkline Llc
  4. 0173-0681
  5. NDC Package Code: 0173-0681-22 Relenza

NDC Package 0173-0681-22 Relenza

Zanamivir Powder Respiratory (inhalation) - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0173-0681-22
Package Description:
5 PACKAGE in 1 CARTON / 4 POWDER in 1 PACKAGE
Product Code:
0173-0681
Proprietary Name:
Relenza
Non-Proprietary Name:
Zanamivir
Substance Name:
Zanamivir
Usage Information:
Zanamivir is used to treat symptoms caused by the flu virus (influenza) if you have had symptoms for 2 days or less. It helps lessen symptoms (such as stuffy nose, cough, sore throat, fever/chills, headache, body aches, tiredness) and shortens the recovery time by about 1 to 2 days. Zanamivir may also be used to prevent the flu if you have been exposed to someone who already has the flu (such as a sick household member) or if there is a flu outbreak in the community. Talk to your doctor for more details. This medication works by stopping the flu virus from growing. It is not a substitute for the flu vaccine. If you have the flu, zanamivir does not reduce the risk of giving the flu to others.
11-Digit NDC Billing Format:
00173068122
NDC to RxNorm Crosswalk:
  • RxCUI: 759471 - zanamivir 5 MG/INHAL Dry Powder Inhaler, 20 Blisters
  • RxCUI: 759471 - 20 ACTUAT zanamivir 5 MG/ACTUAT Dry Powder Inhaler
  • RxCUI: 759471 - zanamivir 5 MG/ACTUAT Dry Powder Inhaler, 20 ACTUAT
  • RxCUI: 759473 - RELENZA DISKHALER 5 MG/INHAL Dry Powder Inhaler, 20 Blisters
  • RxCUI: 759473 - 20 ACTUAT zanamivir 5 MG/ACTUAT Dry Powder Inhaler [Relenza]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Glaxosmithkline Llc
    Dosage Form:
    Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
    Administration Route(s):
  • Respiratory (inhalation) - Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect.
    • Active Ingredient(s):
  • ZANAMIVIR 5 mg/1
    • Pharmacologic Class(es):
  • Neuraminidase Inhibitor - [EPC] (Established Pharmacologic Class)
  • Neuraminidase Inhibitors - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    NDA021036
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    09-22-1999
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    0173-0681-015 PACKAGE in 1 CARTON / 4 POWDER in 1 PACKAGE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0173-0681-22?

    The NDC Packaged Code 0173-0681-22 is assigned to a package of 5 package in 1 carton / 4 powder in 1 package of Relenza, a human prescription drug labeled by Glaxosmithkline Llc. The product's dosage form is powder and is administered via respiratory (inhalation) form.

    Is NDC 0173-0681 included in the NDC Directory?

    Yes, Relenza with product code 0173-0681 is active and included in the NDC Directory. The product was first marketed by Glaxosmithkline Llc on September 22, 1999 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 0173-0681-22?

    The 11-digit format is 00173068122. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20173-0681-225-4-200173-0681-22